Genomic testing in high-grade serous ovarian cancer: current options and future development

被引：0
作者：
Devlin, Michael-John [1 ,2 ]
Miller, Rowan [2 ,3 ,4 ]
机构：
[1] Queen Mary Univ London, Barts Canc Inst, London, England
[2] St Bartholomews Hosp, Dept Med Oncol, London, England
[3] Univ Coll London Hosp, Dept Med Oncol, London, England
[4] Univ Coll London Hosp NHS Fdn Trust, Med Oncol, London NW1 2PG, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / 03期
关键词：
Medical Oncology; Ovary; Cystadenocarcinoma; Serous; HOMOLOGOUS RECOMBINATION DEFICIENCY; OLAPARIB MAINTENANCE THERAPY; MISMATCH REPAIR DEFICIENCY; REVERSION MUTATIONS; PARP INHIBITORS; DNA-REPAIR; PLATINUM; BRCA; SENSITIVITY; MECHANISM;
D O I：
10.1136/ijgc-2022-003702
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Understanding the genomic complexity of high-grade serous ovarian cancer is now essential in guiding patient management, particularly in the first-line setting. Our knowledge in this area has expanded rapidly in recent years, with biomarkers developing in parallel to agents designed to exploit cancer-associated genetic aberrations. In this review we will take stock of the current landscape of genetic testing and look towards the future with developments that aim to refine personalized treatment paradigms and track treatment resistance in real time.
引用
收藏
页码：358 / 363
页数：6
相关论文
共 50 条
[31]   BRCA Status Does Not Predict Synergism of a Carboplatin and Olaparib Combination in High-Grade Serous Ovarian Cancer Cell Lines [J].
Shen, Yen Ting ;
Evans, James C. ;
Zafarana, Gaetano ;
Allen, Christine ;
Piquette-Miller, Micheline .
MOLECULAR PHARMACEUTICS, 2018, 15 (07) :2742-2753
[32]   Dynamically Accumulating Homologous Recombination Deficiency Score Served as an Important Prognosis Factor in High-Grade Serous Ovarian Cancer [J].
Su, Rongjia ;
Liu, Yuan ;
Wu, Xiaomei ;
Xiang, Jiangdong ;
Xi, Xiaowei .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
[33]   Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions [J].
Alkema, Nicolette G. ;
Wisman, G. Bea A. ;
van der Zee, Ate G. J. ;
van Vugt, Marcel A. T. M. ;
de Jong, Steven .
DRUG RESISTANCE UPDATES, 2016, 24 :55-69
[34]   Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer [J].
Parkes, Eileen E. ;
Kennedy, Richard D. .
ONCOLOGIST, 2016, 21 (05) :586-593
[35]   A Benchmark of In-House Homologous Recombination Repair Deficiency Testing Solutions for High-Grade Serous Ovarian Cancer Diagnosis [J].
Guarischi-Sousa, Rodrigo ;
Kroll, Jose Eduardo ;
Bonaldi, Adriano ;
Pierry, Paulo Marques ;
Villela, Darine ;
Souza, Camila Alves ;
Silva, Juliana Santos ;
Buerger, Matheus Carvalho ;
Oliveira, Felipe Azevedo ;
de Paula, Marcelo Gomes ;
Meliso, Fabiana Marcelino ;
de Almeida, Luiz Gustavo ;
Monfredini, Priscilla Morais ;
de Oliveira, Ana Gabriela ;
Milanezi, Fernanda ;
Scapulatempo-Neto, Cristovam ;
Yamamoto, Guilherme Lopes .
DIAGNOSTICS, 2023, 13 (21)
[36]   Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer [J].
Shen, Yen Ting ;
Wang, Lucy ;
Evans, James C. ;
Allen, Christine ;
Piquette-Miller, Micheline .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
[37]   Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer [J].
Buttarelli, Marianna ;
De Donato, Marta ;
Raspaglio, Giuseppina ;
Babini, Gabriele ;
Ciucci, Alessandra ;
Martinelli, Enrica ;
Baccaro, Pina ;
Pasciuto, Tina ;
Fagotti, Anna ;
Scambia, Giovanni ;
Gallo, Daniela .
CANCERS, 2020, 12 (04)
[38]   Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer [J].
Evangelisti, Giulio ;
Barra, Fabio ;
Moioli, Melita ;
Sala, Paolo ;
Stigliani, Sara ;
Gustavino, Claudio ;
Costantini, Sergio ;
Ferrero, Simone .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) :779-792
[39]   Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer [J].
Ohman, Anders W. ;
Hasan, Noor ;
Dinulescu, Daniela M. .
FRONTIERS IN ONCOLOGY, 2014, 4
[40]   Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas [J].
Milanesio, Michela Camilla ;
Giordano, Silvia ;
Valabrega, Giorgio .
CANCERS, 2020, 12 (05)
12345